Background: Osteoporosis is a major contributor to the propensity to fracture among older
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …

Purpose To conduct a systematic review of the literature to detect the effect of anti-resorptive
drugs (ARDs) and their administration characteristics in the development of medication …

Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A
Clinical Practice Guideline Update From the American College of Physicians | Annals of Internal …

Bisphosphonates have been associated with a serious adverse reaction known as
bisphosphonate-related osteonecrosis of the jaws (BRONJ). The aim of this study was to …

Objectives To establish osteonecrosis of the jaws in rats treated with different doses of
zoledronic acid (ZA). Methods Male Wistar rats (n= 6–7) received three consecutive weekly …

Osteonecrosis of the jaws (ONJ) is a complex disease involving multiple tissue and cell-type
responses to wound healing or infection. AAOMS defines bisphosphonate related ONJ …

Oral bisphosphonates are the most commonly prescribed antiresorptive drugs for the
treatment of osteoporosis. However, there are several adverse effects associated with oral …

A retrospective analysis was performed with the aim of understanding whether the risk
factors showed in the literature for medication-related osteonecrosis of the jaws (MRONJ) in …

Objective Osteonecrosis of the jaw (ONJ) is a potentially severe adverse effect of various
medications (bisphosphonates, anti‐resorptive, and anti‐angiogenic drugs). ONJ …

Objective To assess the main clinical, radiographic, and histopathologic features of patients
with bisphosphonate-induced osteonecrosis of the jaws (BIONJ). Study Design Patients with …